Surgical treatment of intramedullary ependymomas by Prokopienko, Marek et al.
Original research article
Surgical treatment of intramedullary ependymomas
Marek Prokopienko, Przemysław Kunert *, Anna Podgórska,
Andrzej Marchel
Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 4 3 9 – 4 4 5
a r t i c l e i n f o
Article history:
Received 11 November 2016
Accepted 30 June 2017
Available online 8 July 2017
Keywords:
Intramedullary ependymoma
Surgery
Outcome
Intraoperative monitoring
a b s t r a c t
Object: The aims of this study were to present the results of surgery for intramedullary
ependymomas (IEs), analyze complication and recurrence rates, and analyze factors that
might inﬂuence outcome.
Methods: The charts of 29 consecutive patients (women – 8, men – 21; mean age – 38 years;
range: 18–72) operated for IE were retrospectively analyzed. Mean follow-up was 9 years.
Eighteen tumors (62%) were located in the cervical or cervicothoracic spine, and average
tumor length was four spinal levels. Twenty patients (69%) presented with neurological
deﬁcit.
Results: Gross total resections (GTRs) comprised 87% of cases, subtotal resections (STRs) 10%,
and partial resections 3%. The neurological outcome on postoperative day 1 was as follows:
modiﬁed McCormick scale (mMS) grade I – 6%, grade II – 21%, grade III – 21%, grade IV – 31%,
and grade V – 21%; at follow-up, outcomes were mMS grade I – 42%, grade II – 34%, grade III –
10%, and grade V – 14% of patients. Compared to the preoperative period, 69% of patients
deteriorated postoperatively; however, 62% improved or remained without deﬁcit in follow-
up, and deterioration persisted in 24%. The functional results were signiﬁcantly worse when
the intraoperative monitoring potentials dropped below 50% ( p = 0.005) and if the tumor
involved >3 spinal levels ( p = 0.039). Fourteen postoperative complications in 10 patients
(34%) included respiratory failure (14%), pneumonia (7%), urinary infection (10%), bed sores
(10%), and CSF leak (7%). Two tumors progressed after STR, with progression-free survival
times of 5 and 14 years. No recurrence was observed after GTR.
Conclusions: Total tumor resection is the treatment of choice in cases of IEs: no tumor re-
growth occurred after total resection, 86% of patients were independent at follow-up, and
the 10-year survival rate was 79%.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
* Corresponding author at: Department of Neurosurgery, Medical University of Warsaw, Banacha Street 1a, 02-097 Warsaw, Poland.
E-mail addresses: mpro76@tlen.pl (M. Prokopienko), przemyslaw.kunert@wum.edu.pl (P. Kunert).
Abbreviations: CNS, central nervous system; IOM, intraoperative monitoring; DTI, diffusion tensor imaging; SEPs, somatosensory
evoked potentials; MEPs, motor evoked potentials; TES, transcranial electrical stimulation; GTR, gross total resection; STR, subtotal
resection; mMS, modiﬁed McCormick scale.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/pjnnshttp://dx.doi.org/10.1016/j.pjnns.2017.06.008
0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 4 3 9 – 4 4 54401. Objective
Ependymomas constitute from 4% to 6% of all central nervous
system (CNS) tumors and about 15% of intramedullary masses
[1–3]. The peak of their appearance is between the third and
sixth decades of life. These tumors are usually slow growing
and benign [4] but tend to compress adjacent structures rather
than inﬁltrate cord parenchyma, resulting in associated
symptoms. In order of decreasing frequency, presentation
may include neck or back pain, sensory deﬁcits, motor
weakness, and bowel and bladder dysfunction [5]. The aim
of this study was to evaluate the short- and long-term results
of surgery for intramedullary ependymomas, with an effort to
identify factors related with functional outcome.
2. Methods
The charts of 29 consecutive patients operated on for
intramedullary ependymomas during the last 16 years were
retrospectively analyzed. Histopathological conﬁrmation of
the ependymoma was the only inclusion criterion. Ependy-
momas of ﬁlum terminale were not analyzed in this series.
2.1. Clinical evaluation
Patients were evaluated and compared at four time points:
before treatment, on postoperative day one, on the day of
discharge (early outcome), and at a follow-up examination
(late outcome). Follow-up data were obtained from medical
charts, telephone interviews with the patients, and interviews
during individual visits. Patients were assessed with a
modiﬁed McCormick scale (mMS; Table 1) [6], and grades I
and II were considered a satisfactory result. The follow-up
period ranged from 2.5 to 16 years (average 9 years), and the
follow-up data were obtained in all cases.
2.2. Imaging evaluation
All patients underwent contrast-enhanced MRI before surgery
and in follow-up. MR imaging was extended with diffusion
tensor imaging in four patients from the last 4 years of the
analyzed series. The length of the tumor (vertebral levels),
presence of syringomyelia, and location in different spinal
segments were assessed.Table 1 – Comparison of neurological status in different stages
Grade of modiﬁed McCormick scale 
I – Intact neurologically, normal ambulation, minimal dysesthesia 
II – Mild motor or sensory deﬁcit, functional independence 
III – Moderate deﬁcit, limitation of function, independent w/external aid
IV – Severe motor or sensory deﬁcit, limited function, dependent 
V – Paraplegia or quadriplegia, even w/ﬂickering movement 2.3. Neurophysiological monitoring
Intraoperative neurophysiological monitoring (IOM) was rou-
tinely used during the last 19 procedures (65%). The sensory
tract was assessed by somatosensory evoked potentials (SEPs)
elicited by medial nerve and tibial nerve stimulation bilateral-
ly. If IOM was based only on cortical SEP, a 50% drop in
amplitude was considered a signiﬁcant change.
In patients with sensory and motor tract monitoring,
the corticospinal tracts were assessed by motor evoked
potentials (MEPs) and D-wave elicited by transcranial electrical
stimulation. MEPs were recorded from thenar, tibialis anterior,
and/or abductor hallucis muscles bilaterally. For muscle
MEPS, present/absent criteria were used, and for D-wave,
the amplitude decrement was assessed. The surgery was
performed as a stop-and-go procedure based on the IOM
ﬁndings. In cases of signiﬁcant change in neurophysiological
parameters, the dissection was temporarily stopped until the
acceptable values returned again.
2.4. Neuroprotection
Methylprednisolone (Solu-MedrolTM, Pﬁzer Europe) infusion
was routinely started before surgery. The infusion protocol
involved 15 min of a bolus of 30 mg/kg, and at least 23 h of
continuous infusion at 5.4 mg/kg/h. Continuous infusion was
performed for 23 h in 13 cases. Infusion time averaged 60 h. In
six cases of signiﬁcant neurological deﬁcit progression after
surgery, the infusion time exceeded 120 h. There were no
complications related to steroid administration in our series.
2.5. Surgery
All tumors were removed through a posterior approach.
Sixteen (55%) located in the thoracic spine and at the
atlanto-occipital junction were operated on with the patient
in the prone position. Thirteen patients (45%) with tumors in
the cervical spine and at the cervico-thoracic junction were
placed for surgery in a sitting position. The laminectomies
were extended using a suboccipital craniotomy with widening
of the foramen magnum in two patients. A midline dural
incision was made over the dorsal surface of the spinal cord,
followed by lateral dural sutures. The arachnoid and pia mater
were incised at the midline in all cases. In ﬁve cases, several
skip incisions were made to spare crossing vessels over the
midline. The tumor was microsurgically detached from of treatment.
Before surgery Postop. day 1 At discharge Follow-up
Number (%) Number (%) Number (%) Number (%)
9 (31) 2 (6) 3 (10) 12 (42)
6 (21) 6 (21) 9 (31) 10 (34)
 13 (45) 6 (21) 8 (28) 3 (10)
0 (0) 9 (31) 5 (17) 0 (0)
1 (3) 6 (21) 4 (14) 4 (14)
29 (100) 29 (100) 29 (100) 29 (100)
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power, debulked in 17 cases (62%), and removed. In eight
patients (28%), a cavitron ultrasonic surgical aspirator was
used. In the more recent years of the analyzed period, the use
of bipolar coagulation was minimized, and the tumor was
dissected in a one-piece fashion without shrinking and
debulking. The dura was closed in watertight fashion, and
the muscles were sutured in a multilayer approach. Lamino-
plasty was not applied. One patient with massive intratumoral
hemorrhage needed two procedures for gross total tumor
removal. At the ﬁrst operation, the intratumoral hematoma
was evacuated with partial tumor removal. Two days later,
complete tumor removal was successfully achieved.
2.6. Extent of resection of the tumor
The extent of resection was categorized as total, subtotal, or
partial. Gross total resection (GTR) was deﬁned as removal of
100% of visible tumor tissue with no evidence of the tumor
remnant in postoperative MRI. Subtotal resection (STR) meant
that more than 90% of visible tumor mass was removed.
2.7. Rehabilitation
Rehabilitation was initiated at postoperative day 1. Initially
rehabilitation was performed within the bed limits. On day 2,
patients were mobilized and assisted with walking if possible.
2.8. Statistical analysis
Fisher's exact or chi-square test was used to evaluate
signiﬁcance. A p-value <0.05 was taken as statistically
signiﬁcant.
3. Results
3.1. Patients, tumors, and symptoms
There were 8 women (28%) and 21 men (72%) included in this
study (ratio 2.6:1). Age ranged from 18 to 72 years (mean, 38
years). The mean age of patients with anaplastic ependymoma
averaged 37 years; among those with low-grade ependymoma,
the average was 38 years.
The location of the tumors was as follows: cervical spine, 9
(31%); cervicothoracic spine, 9 (31%); spinal cone, 8 (28%); and
thoracic spine, 3 (10%). The tumor length ranged from one to
eight spinal levels (average four levels). In nine (31%) cases,
only one spinal level was occupied. Intramedullary syrinx
coexisted in four (14%) cases.
Twenty patients (69%) presented with neurological deﬁcit.
Among them were nine patients (31%) with progressive
paraparesis, four (14%) with progressive tetraparesis, ﬁve
(17%) with single limb weakness progression, one (3%) with
sensory deﬁcit only, and one (3%) with Brown-Sequard
syndrome. Pain was the main cause of diagnosis in seven
patients (24%). In two cases (7%), the tumor was asymptomat-
ic. Ambulatory status was classiﬁed as grade I in 9 patients
(31%), grade II in 6 (21%), grade III in 13 (45%), and grade V in 1
(3%) according to the preoperative mMS (Table 1).3.2. Extent of resection
GTR was accomplished in 25 (87%) patients, STR in 3 (10%), and
partial resection in one (3%). Decisions about subtotal resec-
tions were made intraoperatively. In all three cases, strong
adherence to the spinal cord was the major cause of leaving
small tumor remnants. The decision about partial resection in
one case was made before treatment and was connected with
an atypical appearance of the intramedullary tumor on MRI.
The extent of the resection was conﬁrmed in the postoperative
MRI scans.
3.3. Neuromonitoring
Signiﬁcant changes in intraoperative monitoring records
occurred in eight cases (seven in SEPs and one in SEPs and
MEPs). They returned to normal or mildly decreased values
after approximately 15–60 min in ﬁve cases. In three patients,
they worsened irreversibly.
3.4. Neurological status evaluation on postoperative day
one
On postoperative day 1, the neurological status was as follows:
mMS grade I in two (6%), mMS grade II in six (21%), mMS grade
III in six (21%), mMS grade IV in nine (31%), and mMS grade V in
six (21%) patients (Table 1). Immediately after surgery,
compared to the preoperative status, one patient (3%) im-
proved, and in six (21%) patients, the deﬁcit remained stable.
New neurological deﬁcit appeared in eight patients (28%), and
in twelve (41%), the preoperative deﬁcit increased (Table 2).
Dorsal column dysfunction appeared or increased temporarily
in seven cases (24%). All eight patients with a signiﬁcant decline
in intraoperative SEP and/or MEP values deteriorated after
surgery, including severe deterioration (mMS grades I and V) in
all three patients with an irreversible decrease in responses.
3.5. Intensive care unit
Twelve patients (41%) with cervical or cervicothoracic tumors
were admitted to the intensive care unit (ICU) and discharged
to the neurosurgical ward when cardiorespiratory condition
was stable. The mean stay in ICU was 15 days (range: 3–474
days). Prolonged respiratory failure occurred in four patients
(44% of patients with cervical ependymomas).
3.6. Neurological status at discharge
Hospital stay ranged from 8 to 490 days (mean, 40 days; median,
23 days). At discharge, the neurological condition was as follows:
mMS grade I in three (10%), grade II in nine (31%), grade III in eight
(28%), grade IV in ﬁve (17%), and grade V in four (14%) patients
(Table 1). Fifteen patients (48%) improved or maintained their
good neurological status compared to the ﬁrst day after surgery,
and in fourteen (52%), the deﬁcit remained unchanged (Table 2).
However, compared to the preoperative period, preexisting
neurological deﬁcit deteriorated in eight (28%) and a new deﬁcit
appeared in seven patients (24%). Four patients (14%) improved
or maintained their good neurological status. Preoperative deﬁcit
unchanged in 10 patients (34%) until discharge.
Table 2 – Evolution of neurological condition in different time periods.
Neurological status
change
From pre-op. period to
post-op. day 1
From post-op. day 1 to
discharge
From discharge to
last follow-up
From pre-op. period to
last follow-up
Stable, no deﬁcit 2 (7%) 2 (7%) 2 (7%) 6 (21%)
Improvement 1 (3%) 13 (45%) 19 (66%) 12 (41%)
Stable deﬁcit 6 (21%) 14 (48%) 8 (27%) 4 (14%)
Deterioration 20 (69%) 0 0 7 (24%)
29 (100%) 29 (100%) 29 (100%) 29 (100%)
Pre-op.: preoperative, post-op.: postoperative.
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Histopathological examination demonstrated WHO grade II
ependymoma in 26 (90%) cases and WHO grade III ependy-
moma in 3 (10%). The 2016 WHO Classiﬁcation of Tumors of
the Central Nervous System was not used in the current study
because the histopathological diagnosis had been established
in all cases before its introduction.
3.8. Radiotherapy
Seven (27%) patients were referred to regional oncology
centers. Radiotherapy was initiated in three patients with
anaplastic tumors and in four after partial or subtotal resection
of WHO grade II ependymoma. No side effects of radiation
treatment were observed.
3.9. Neurological status evaluation at follow-up
All patients were reached at follow-up, which averaged 9 years
(range: 1–16 years). Neurological status was as follows: mMS
grade I in 12 (42%), mMS grade II in 10 (34%), mMS grade III in
3 (10%), and mMs grade V in 4 (14%) patients (Table 1).
Six patients died, four (14%) from a severe postoperative
neurological condition and two (7%) for reasons not related toFig. 1 – The Kaplan–Meier survival plot, patients after
surgery for intramedullary ependymomas.the intramedullary tumor. The 3-, 5-, and 10-year survival
rates were 82%, 79%, and 79%, respectively. The Kaplan–Meier
survival curve is presented in Fig. 1.
Compared to the preoperative status, an improvement or
stable mMS grade I was noted in 18 patients (62%), stable deﬁcit
in 4 (14%), and deterioration in 7 (24%; Table 2). Improvement
was noted in 23 (80%) patients compared to postoperative day
one. Only in four cases (14%) did the postoperative deﬁcit
remain unchanged.
Among nine patients without neurological deﬁcit before
treatment, ﬁve patients (56%) ﬁnally reached mMS grade I,
three patients (33%) had grade II, and one patient (11%) grade
III (satisfactory outcome in 89%; Table 3). Among 20 patients
presenting with deﬁcit, 7 patients (35%) reached mMS grade I,
7 (35%) grade II, 2 (10%) grade III, and 4 (20%) grade V
(satisfactory outcome, 70%; p = NS).
Among four patients with intraoperative potentials lost,
the severe postoperative deﬁcit remained in two cases, and
two patients improved to mMS grade II in follow-up.
3.10. Factors that might inﬂuence the outcome
The analysis of factors that might inﬂuence the long-term
outcome and the risk of permanent deterioration after tumor
excision are presented in Tables 3 and 4. Nonsigniﬁcantly
better outcomes compared to the opposite subgroups were
associated with the following factors: age <40 years, female
sex, good preoperative neurological status, and intramedullary
syrinx. We found that the functional results were signiﬁcantly
worse when the IOM potentials dropped below 50% ( p = 0.005)
or if the tumor involved more than three spinal levels
( p = 0.039; Table 3). Seven out of nine patients (78%) with
tumors occupying only one spinal level achieved mMS grade I
during follow-up. Improvement or a good stable (mMS grade I)
condition during follow-up, compared to preoperative status,
was noted in 11 out of 14 patients (79%) with tumors at ≤3
spinal levels, and only in 7 (46%) out of 15 with larger tumors
( p = 0.08; Table 4).
3.11. Postoperative complications and tumor recurrence
Fourteen postoperative complications in 10 patients (34%)
included respiratory failure in four cases (14%), pneumonia
in two (7%), urinary infection in three (10%), bed sores in
three (10%), and a cerebrospinal ﬂuid leak in two (7%). The
cerebrospinal ﬂuid leak was treated successfully with wound
compression and acetazolamide.
Two tumors progressed after STR in follow-up, and the
progression-free survival was 5 and 14 years in these patients.
Table 3 – Analysis of factors that might influence the long-term outcome of surgical tumor excision.
Factor Follow-up (McCormick classiﬁcation) p value
(Fisher's exact or chi-square test)
Grades I–II Grades III–V
Age < 40 14 (82%) 3 (18%) NS
Age ≥ 40 8 (67%) 4 (33%)
Female sex 7 (87.5%) 1 (12.5%) NS
Male sex 15 (71%) 6 (29%)
Preoperative deﬁcit // 8 (89%) 1 (11%) NS
Preoperative deﬁcit /+/ 14 (70%) 6 (30%)
mMS grades I–II preop. 13 (87%) 2 (13%) NS
mMS grades III–V preop. 9 (64%) 5 (36%)
Spinal levels ≤3 13 (93%) 1 (7%) p = 0.039
Spinal levels >3 9 (60%) 6 (40%)
Syrinx /+/ 4 (100%) 0 (0%) NS
Syrinx // 18 (72%) 7 (28%)
IOM potentials stable 11 (100%) 0 (0%) p = 0.005
IOM potentials drop < 50% 3 (37.5%) 5 (62.5%)
IOM not used 7 (70%) 3 (30%) NS
IOM used 14 (74%) 5 (26%)
NS: no signiﬁcant difference between subgroups.
Table 4 – Analysis of factors that might influence the risk of long-term postoperative deterioration in relation to
preoperative condition.
Factor Evolution of neurological condition in follow-up p value
(Fisher exact test)
Improvement or stable mMS grade I Stable deﬁcit Deterioration
Age <40 years 13 (72%) 2 (11%) 3 (17%) NS
Age ≥40 years 5 (46%) 2 (18%) 4 (36%)
Female sex 6 (75%) 0 (0%) 2 (25%) NS
Male sex 12 (57%) 4 (19%) 5 (24%)
Any preoperative deﬁcit // 5 (56%) 0 (0%) 4 (44%) NS
Any preoperative deﬁcit /+/ 13 (65%) 4 (20%) 3 (15%)
mMS grades I–II preop. 8 (54%) 2 (13%) 5 (33%) NS
mMS grades III–V preop. 10 (72%) 2 (14%) 2 (14%)
Spinal levels ≤3 11 (79%) 0 (0%) 3 (21%) p = 0.08
Spinal levels >3 7 (46%) 4 (27%) 4 (27%)
Syrinx /+/ 4 (100%) 0 (0%) 0 (0%) NS
Syrinx // 14 (56%) 4 (16%) 7 (28%)
IOM potentials stable 8 (73%) 2 (18%) 1 (9%) NS
IOM potentials drop <50% 3 (37.5%) 2 (25%) 3 (37.5%)
IOM not used 5 (50%) 1 (10%) 4 (40%) NS
IOM used 11 (58%) 4 (36%) 4 (36%)
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either of these patients on follow-up MRI. No other recurrences
were observed.
4. Discussion
4.1. Patients, tumors, and symptoms
In the analyzed series, the intramedullary ependymomas were
diagnosed predominantly in males (72%) and in the cervical or
cervicothoracic spine (62%). In other series, the percentage of
males ranged from 43% to 82%, and the cervical location of the
tumor ranged from 61% to 66% [7–9]. Intramedullary ependy-
momas involved only one spinal segment in 31% of cases in
our series whereas Alkhani et al. [8] noted a small tumor size inthe majority of patients. Neurological deﬁcit was the main
cause of diagnosis in 69% of our patients, similar to the
ﬁndings of Kane et al. [10], who observed preoperative deﬁcits
in 72% of patients. The percentage of totally resected tumors in
this study (87%) is close to the value Klekamp [11] reported,
which was 86% of totally resected ependymomas.
4.2. Timing of surgery
Two major groups were used for the analysis: patients with
preoperative neurological deﬁcit and those who were neuro-
logically intact. Satisfactory outcome was noted in 8 patients
(89%) without preoperative deﬁcit and in 14 patients (70%)
presenting with neurological deﬁcit in our series. Although the
difference was not signiﬁcant, our strategy is based on the
belief that the early treatment of oligo- and asymptomatic
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follow-up. Some authors still choose a watch-and-wait strategy
in cases of asymptomatic intramedullary tumors [12–14], but
our results encouraged us to start treatment as early as
possible. Similar observations in recent literature conﬁrm that
the best outcomes are achieved in patients with good
preoperative status [15–22]. Preoperative neurological deﬁcit
reﬂects the damage to the spinal cord caused by the tumor, and
the operative procedure increases this damage. Therefore,
waiting for more symptoms leads to increasing irreversible
spinal cord damage before surgery and worsens the overall
outcome. Brotchi et al. [15] and Halvorsen et al. [16] in large
series of treated ependymomas found good neurological status
to be the main prognostic factor determining favorable
postoperative outcome. Brotchi et al. [15] additionally recom-
mended that patients with intramedullary tumors should be
operated when they are still able to walk. Alkhani et al. [8]
emphasized early diagnosis and referral to specialized surgical
centers as factors improving the outcome. Preoperative
neurological status was the only statistically signiﬁcant factor
in their series. They found that all patients who originally
presented with mMS grade I continued with the same grade 6
months postoperatively. Patients who presented with mMS
grades III and IV remained the same in long-term observation
after the procedure. The importance of surgery carried out
immediately after diagnosis is underlined also by Epstein et al.
[20]. Unfavorable operative treatment results were reported for
14% of patients in good preoperative status and 67% of patients
in poor neurological condition in their series.
4.3. Factors inﬂuencing the outcome
The functional results were not signiﬁcantly different depend-
ing on age, sex, the use of IOM, preoperative neurological deﬁcit,
and syrinx presence. In contrast, a larger size of the tumor (>3
spinal levels) and a drop in IOM potentials of 50% or more were
associated with signiﬁcantly worse outcomes in this study.
Eroes et al. [21] also found a statistically signiﬁcant difference
between groups with an advantage of smaller ependymomas.
They noted the best results in patients with tumors of less than
ﬁve levels. In the material of Li et al. [7], good operative
treatment results were achieved in 23% of patients with smaller
tumors (up to 5 cm) and 44% patients with larger tumors. It is
understandable that the smaller the tumor size, the smaller the
operative injury to the spinal cord. However, Alkhani et al. [8]
did not ﬁnd that tumor size was a prognostically valuable
feature, emphasizing good preoperative status as the only
important factor resulting in a satisfactory outcome. In our
series, the patients who were neurologically intact at presenta-
tion had slightly better results compared to those with deﬁcits
before surgery (mMS grades I and II: 89% vs. 70%, p = NS). On the
other hand, it should be mentioned that a minor postoperative
deﬁcit persisted during follow-up in 44% of patients who had no
deﬁcit before the treatment (Table 4).
A signiﬁcant drop in IOM values was associated with
signiﬁcantly worse results in our series. Currently, intraoper-
ative neuromonitoring is the essential tool for intramedullary
surgery assurance and should be obligatory. Patients with
intramedullary neoplasms should be treated in specialized
centers equipped with IOM devices and by clinicians who haveadequate surgical experience [11]. All monitored potentials
should be carefully analyzed during the whole resection, and
their changes should affect surgeon behavior. Dorsal column
mapping was not used in analyzed group. As this technique
has proven to be safe and effective method for identifying
functional midline of the spinal cord, it may reduce injury to
the posterior columns [23].
Nonsigniﬁcantly better results have been found in younger
patients. Klekamp recognized young age as predictive for better
functional outcome in his series [11], noting unfavorable results
in 24% of younger patients (≤60 years) and in 44% of older
patients. These observations can be explained by a worse initial
condition and worse rehabilitation results in older patients.
However, most authors do not share this opinion [16,19,21].
4.4. Extent of resection
Our rate of non-total resections (13%) is very similar to that of
Klekamp's series [11] and seems to be a good result. The
percentage of non-total resections in other series ranged from
18% to 35% [7,8,10,12,16]. Strong adherence to the surrounding
spinal cord and IOM recording decreases forced us to leave
small pieces of the tumor in three cases. The atypical MR
appearance of the tumor was the cause of partial resection in
one case. Among these four, revision surgery was needed in
two patients. No recurrence was noted after GTR. Our results
allow us to conclude that the surgical priority is the maximal
safe resection, which in the case of ependymoma usually
means a total resection.
An attitude of watchful waiting with the residual tumor
after primary surgery is supported by Halvorsen et al. in their
study [16]. They found spontaneous regression of the tumor
remnant after non-total resections in 37% of cases. Radiation
therapy used in patients after partial and subtotal resection
also could have resulted in good control of the growth of non-
radically removed tumors. It has been well established that an
early start of adjuvant treatment after non-total resection
prolongs progression-free survival [24,25]. Radiation therapy is
not recommended after total resection of benign ependy-
moma, which is considered as the gold standard in its
operative treatment [12–28].
Beyond the benign ependymoma remnants, the high-
grade forms, even if totally removed, require radiation
therapy, although recently published studies suggest that it
is not associated with a lower overall recurrence rate [29,30].
We did not refer our patients for chemotherapy, which has
only a modest effect on ependymomas [30]. Ten percent of
anaplastic ependymomas in our series is a rather small
number compared to 30% in the series of Li et al. [7] and
Klekamp [11].
4.5. Functional results of surgery and their evolution
Because the results of surgery in our series are satisfactory in
76% of the patients and 87% were independent in everyday
life, the overall outcome seems to be positive. Comparably
to Klekamp [11], we found that the majority of patients
demonstrated deterioration immediately after surgery;
however, early rehabilitation brought functional improve-
ment.
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The incidence of postoperative complications in the analyzed
series was relatively high (34%). Respiratory failure was related
to the cervical location of the tumor. Infectious complications
occurred mainly in bedridden patients with severe postopera-
tive deﬁcit. In the series of Klekamp, a lower rate (17%) of
complications probably was related to the better neurological
status of patients immediately after surgery [11].
5. Conclusions
Complete tumor resection plays a key role in intramedullary
ependymoma treatment because no tumor regrowth occurred
after total resection, 86% of patients were independent in follow-
up, and the 10-year survival rate was 79%. The functional results
were signiﬁcantly worse when the IOM potentials dropped
below 50% or if the tumor involved more than three spinal levels.
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